Market Overview

UPDATE: Wedbush Maintains Tempur-Pedic International at Neutral Following Sealy Deal

Related TPX
Tempur Sealy Announces Acquisition Of Sealy Brand Rights In Japan
Mattress Firm Leading the Pack After Upgrade

Wedbush reiterated its Neutral rating and $27 price target on Tempur-Pedic International (NYSE: TPX) following agreement to purchase Sealy (NYSE: ZZ).

Wedbush commented, "The acquisition should be accretive during the first year, and the company expects annual operating cost savings of $40 million by the third year. In addition to operational cost savings (primarily through purchasing and supply chain), Tempur-Pedic has been able to refinance Sealy's debt obligations for a much lower interest rate, and it expects to reduce the company's combined leverage to an optimal level within four to five years. … Many questions remain as to what level of integration the combined company will pursue, and how this may affect future financial results."

Tempur-Pedic International closed at $30.33 on Thursday.

Posted-In: WedbushAnalyst Color News Reiteration M&A Analyst Ratings

 

Most Popular

Related Articles (TPX + ZZ)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free